This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jahed A. Hamdan, MD; Khader Manasra, MD; Mohammed Ahmed, MD

Am J Dis Child. 1985;139(5):453-455.

Abstract
• In a 4-year retrospective study of hospitalized patients with rheumatic fever treated with salicylates, we determined that five of 34 children manifested salicylate-induced hepatitis. The average serum salicylate level in those patients with hepatotoxicity was 30.9 mg/dL, while the average serum salicylate level in the rest of the patients was 19.7 mg/dL. An awareness of this potential complication is important when treating children with salicylates at doses previously considered to be nontoxic. Serum salicylate levels should be maintained at approximately 15 to 25 mg/dL during such therapy.

(AJDC 1985;139:453-455)

Author Affiliations
From the Department of Pediatrics, Dhahran (Saudi Arabia) Health Center.

Footnotes
Reprint requests to Chief, Pediatrics, Pediatric Services, Dhahran Health Center, Box 76, Dhahran, Saudi Arabia (Dr Hamdan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?